| Dr Amanda Rhodes, AUD | |
|
7 Cobblestone Dr. St. 10, Turner, ME 04282 | |
| (207) 224-0222 | |
| (207) 224-0040 |
| Full Name | Dr Amanda Rhodes |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 5 Years |
| Location | 7 Cobblestone Dr. St. 10, Turner, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497316004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AP2981 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Red Maple Audiology Llc | 0749695542 | 3 |
News Archive
The leading innovator in incentive compensation (ICM) and sales performance management (SPM) solutions, Varicent Software Incorporated, announced today a successful "go live" of Varicent for Alcon Japan Ltd.
Logical Therapeutics, Inc., a private, clinical stage biopharmaceutical company, announced today it had closed on a $16.9 million Series C equity financing. The round was led by existing investor SV Life Sciences, and included Burrill & Company, Novo A/S and Novitas Capital.
Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.
Joint replacement surgery carries the risk of developing an infection in the replaced joint, which can lead to a so-called revision or re-do of the joint replacement.
› Verified 1 days ago
| Provider Name | Red Maple Audiology Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538704044 PECOS PAC ID: 0749695542 Enrollment ID: O20210208002602 |
News Archive
The leading innovator in incentive compensation (ICM) and sales performance management (SPM) solutions, Varicent Software Incorporated, announced today a successful "go live" of Varicent for Alcon Japan Ltd.
Logical Therapeutics, Inc., a private, clinical stage biopharmaceutical company, announced today it had closed on a $16.9 million Series C equity financing. The round was led by existing investor SV Life Sciences, and included Burrill & Company, Novo A/S and Novitas Capital.
Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.
Joint replacement surgery carries the risk of developing an infection in the replaced joint, which can lead to a so-called revision or re-do of the joint replacement.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Rhodes, AUD 7 Cobblestone Dr. St. 10, Turner, ME 04282 Ph: (207) 224-0222 | Dr Amanda Rhodes, AUD 7 Cobblestone Dr. St. 10, Turner, ME 04282 Ph: (207) 224-0222 |
News Archive
The leading innovator in incentive compensation (ICM) and sales performance management (SPM) solutions, Varicent Software Incorporated, announced today a successful "go live" of Varicent for Alcon Japan Ltd.
Logical Therapeutics, Inc., a private, clinical stage biopharmaceutical company, announced today it had closed on a $16.9 million Series C equity financing. The round was led by existing investor SV Life Sciences, and included Burrill & Company, Novo A/S and Novitas Capital.
Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.
Joint replacement surgery carries the risk of developing an infection in the replaced joint, which can lead to a so-called revision or re-do of the joint replacement.
› Verified 1 days ago
Red Maple Audiology, Llc Audiologist Medicare: Medicare Enrolled Practice Location: 7 Cobblestone Dr Unit 10, Turner, ME 04282 Phone: 207-224-0222 Fax: 207-224-0040 | |
Dr. Rebecca Haley Goodman, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7 Cobblestone Dr Ste 10, Turner, ME 04282 Phone: 207-224-0222 | |
Ashlee Harrington Vandiver, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 7 Cobblestone Dr Ste 10, Turner, ME 04282 Phone: 207-224-0222 Fax: 207-224-0040 | |
Dr. Jenna Palazzolo, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 7 Cobblestone Dr. Suite 10, Turner, ME 04282 Phone: 207-224-0222 Fax: 207-224-0040 |